[DGX] Quest Diagnostics Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 92.41 Change: 0.61 (0.66%)
Ext. hours: Change: 0 (0%)

chart DGX

Refresh chart

Strongest Trends Summary For DGX

DGX is in the medium-term up 11% above S&P in 7 months and up 24% in 1 year. In the long-term up 121% in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. In addition, it provides molecular diagnostic products in various segments, such as HIV-1 drug resistance testing under the ViroSeq brand name; and reproductive genetics and transplantation under the

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters-95.95% EPS Growth - Q/Q-97.76%
EPS Growth - Y/Y-46.52% Sales Growth - 4 Quarters -3.31% Sales Growth - Q/Q-2.34% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA4.83% ROE12.09% ROI6.04%
Current Ratio1.14 Quick Ratio1.09 Long Term Debt/Equity12.9 Debt Ratio0.49
Gross Margin37.58% Operating Margin13.32% Net Profit Margin6.81% Dividend Payout Ratio-44.83%
Dividend Yield
Fundamental Data
Cash From Financing Activities-246 M Cash From Investing Activities-123 M Cash From Operating Activities327 M Gross Profit747 M
Net Profit118 M Operating Profit301 M Total Assets9.72 B Total Current Assets1.53 B
Total Current Liabilities1.24 B Total Debt3.74 B Total Liabilities5.41 B Total Revenue1.93 B
Technical Data
High 52 week110.9 Low 52 week79.25 Last close100.74 Last change-0.48%
RSI56.84 Average true range2.47 Beta0.67 Volume278.29 K
Simple moving average 20 days-0.25% Simple moving average 50 days0.16% Simple moving average 200 days9.27%
Performance Data
Performance Week0.4% Performance Month-2.67% Performance Quart2.1% Performance Half13.74%
Performance Year-6.33% Performance Year-to-date21.75% Volatility daily1.64% Volatility weekly3.66%
Volatility monthly7.5% Volatility yearly25.98% Relative Volume285.51% Average Volume920.59 K
New High New Low

News

2019-09-17 09:40:01 | DGX vs. ADUS: Which Stock Is the Better Value Option?

2019-09-17 09:10:01 | Is Quest Diagnostics DGX a Great Value Stock Right Now?

2019-09-16 07:52:28 | What Should We Expect From Quest Diagnostics Incorporated's NYSE:DGX Earnings In The Year Ahead?

2019-09-12 08:00:00 | Quest Diagnostics and hc1 Collaborate to Optimize Enterprise-wide Laboratory Testing for Health Systems

2019-09-11 14:00:00 | Workforce Drug Positivity Increases in More Than One-Third of U.S. Industry Sectors Examined, According to Quest Diagnostics Multi-Year Analysis

2019-09-11 13:13:00 | A growing share of workers in these industries is failing drug tests — and public safety could be at risk

2019-09-11 09:10:01 | Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch

2019-09-11 09:00:01 | All You Need to Know About Quest Diagnostics DGX Rating Upgrade to Buy

2019-09-10 16:02:00 | Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader

2019-08-30 08:46:55 | Is It Too Late To Consider Buying Quest Diagnostics Incorporated NYSE:DGX?

2019-08-29 09:56:01 | Quest Diagnostics' New Acquisitions and Pacts Aid Growth

2019-08-28 16:41:00 | Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference

2019-08-28 06:29:25 | LabCorp joins in $17.5M round for Cambridge diagnostic startup Boston Microfluidics

2019-08-23 14:14:00 | Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference

2019-08-22 09:30:01 | Why Is Quest Diagnostics DGX Down 0.2% Since Last Earnings Report?

2019-08-21 07:30:00 | Why a $4.9 Billion Fund Is Betting on Berkshire Hathaway, Dollar Tree, and Quest Diagnostics

2019-08-20 09:50:01 | Should Value Investors Pick Quest Diagnostics DGX Stock?

2019-08-16 08:53:12 | Outlook for Outpatient and Home Healthcare Industry Looks Bright

2019-08-15 17:27:26 | Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future

2019-08-15 06:45:00 | Quest Diagnostics Declares Quarterly Cash Dividend

2019-08-13 18:35:47 | Chris Davis Buys 3 Stocks in 2nd Quarter

2019-08-13 15:02:19 | Can You Imagine How Quest Diagnostics's NYSE:DGX Shareholders Feel About The 62% Share Price Increase?

2019-08-06 15:23:33 | Oxford Immunotec Global PLC OXFD Q2 2019 Earnings Call Transcript

2019-07-26 09:30:01 | DGX vs. LHCG: Which Stock Is the Better Value Option?

2019-07-24 08:38:28 | Is Quest Diagnostics Incorporated NYSE:DGX Better Than Average At Deploying Capital?

2019-07-23 22:18:17 | Edited Transcript of DGX earnings conference call or presentation 23-Jul-19 12:30pm GMT

2019-07-23 15:00:00 | What You Need to Know About Quest Diagnostics' Q2 Earnings Results

2019-07-23 09:50:01 | Quest Diagnostics DGX Q2 Earnings, Revenues Beat Estimates

2019-07-23 06:58:00 | Quest Diagnostics Shares Surge After Healthy Quarterly Results

2019-07-23 06:45:00 | Quest Diagnostics Reports Second Quarter 2019 Financial Results

2019-07-23 06:30:00 | Quest Diagnostics, Inc. to Host Earnings Call

2019-07-22 15:42:46 | Quest Diagnostics Reports in a Bear Market Decline

2019-07-19 22:50:00 | QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

2019-07-18 10:42:02 | Will 2-Pronged Plan Aid Quest Diagnostics DGX Q2 Earnings?

2019-07-18 06:00:00 | Quest Diagnostics Welcomes New Members to the Global Diagnostics Network GDN

2019-07-17 08:49:16 | Another 2.2 million patients affected by AMCA data breach

2019-07-17 08:01:00 | Quest Diagnostics Named one of the _Best Places to Work for Disability Inclusion_

2019-07-17 06:45:00 | Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services

2019-07-16 10:31:02 | Earnings Preview: Quest Diagnostics DGX Q2 Earnings Expected to Decline

2019-07-12 09:30:00 | Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

2019-07-09 13:48:00 | Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23

2019-07-09 08:01:03 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

2019-07-09 07:41:11 | Women Health a Top Priority Now: 3 Stocks to Watch

2019-06-21 22:50:00 | QUEST DIAGNOSTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

2019-06-18 09:30:01 | DGX vs. CHE: Which Stock Is the Better Value Option?

2019-06-18 08:15:57 | Is Quest Diagnostics Incorporated NYSE:DGX A Smart Pick For Income Investors?

2019-06-17 19:15:04 | Quest Diagnostics Inc DGX Chairman, President and CEO Stephen H Rusckowski Sold $24. ...

2019-06-17 18:35:58 | Debt Collector Goes Bankrupt After Health Care Data Hack

2019-06-17 09:00:00 | Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study

2019-06-11 08:01:41 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.